Medicare Rx May Necessitate Drug Comparison Studies In Early Development
Executive Summary
Manufacturers are conducting comparative efficacy analyses in the early stages of drug development to anticipate how their products' value will be judged as a result of the Medicare Modernization Act, Sanofi-Aventis Director-Public Policy Jean-Paul Gagnon told the Pharmaceutical Marketing Congress Sept. 12 in Philadelphia